Cargando…
Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant genetic disorder with patients typically showing heterozygous inheritance of a pathogenic variant in a gene encoding a contractile protein. Here, we study the contractile effects of a rare homozygous mutation using explanted tiss...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier, Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160007/ https://www.ncbi.nlm.nih.gov/pubmed/37159677 http://dx.doi.org/10.1016/j.jmccpl.2022.100007 |
_version_ | 1785037194038083584 |
---|---|
author | Sequeira, Vasco Wang, Lili Wijnker, Paul J.M. Kim, Kyungsoo Pinto, Jose R. dos Remedios, Cris Redwood, Charles Knollmann, Bjorn C. van der Velden, Jolanda |
author_facet | Sequeira, Vasco Wang, Lili Wijnker, Paul J.M. Kim, Kyungsoo Pinto, Jose R. dos Remedios, Cris Redwood, Charles Knollmann, Bjorn C. van der Velden, Jolanda |
author_sort | Sequeira, Vasco |
collection | PubMed |
description | BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant genetic disorder with patients typically showing heterozygous inheritance of a pathogenic variant in a gene encoding a contractile protein. Here, we study the contractile effects of a rare homozygous mutation using explanted tissue and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to gain insight into how the balance between mutant and WT protein expression affects cardiomyocyte function. METHODS: Force measurements were performed in cardiomyocytes isolated from a HCM patient carrying a homozygous troponin T mutation (cTnT-K280N) and healthy donors. To discriminate between mutation-mediated and phosphorylation-related effects on Ca(2+)-sensitivity, cardiomyocytes were treated with alkaline phosphatase (AP) or protein kinase A (PKA). Troponin exchange experiments characterized the relation between mutant levels and myofilament function. To define mutation-mediated effects on Ca(2+)-dynamics we used CRISPR/Cas9 to generate hiPSC-CMs harbouring heterozygous and homozygous TnT-K280N mutations. Ca(2+)-transient and cell shortening experiments compared these lines against isogenic controls. RESULTS: Myofilament Ca(2+)-sensitivity was higher in homozygous cTnT-K280N cardiomyocytes and was not corrected by AP- and PKA-treatment. In cTnT-K280N cells exchanged with cTnT-WT, a low level (14%) of cTnT-K280N mutation elevated Ca(2+)-sensitivity. Similarly, exchange of donor cells with 45 ± 2% cTnT-K280N increased Ca(2+)-sensitivity and was not corrected by PKA. cTnT-K280N hiPSC-CMs show elevated diastolic Ca(2+) and increases in cell shortening. Impaired cardiomyocyte relaxation was only evident in homozygous cTnT-K280N hiPSC-CMs. CONCLUSIONS: The cTnT-K280N mutation increases myofilament Ca(2+)-sensitivity, elevates diastolic Ca(2+), enhances contractility and impairs cellular relaxation. A low level (14%) of the cTnT-K280N sensitizes myofilaments to Ca(2+), a universal finding of human HCM. |
format | Online Article Text |
id | pubmed-10160007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier, Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-101600072023-05-06 Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy Sequeira, Vasco Wang, Lili Wijnker, Paul J.M. Kim, Kyungsoo Pinto, Jose R. dos Remedios, Cris Redwood, Charles Knollmann, Bjorn C. van der Velden, Jolanda J Mol Cell Cardiol Plus Article BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant genetic disorder with patients typically showing heterozygous inheritance of a pathogenic variant in a gene encoding a contractile protein. Here, we study the contractile effects of a rare homozygous mutation using explanted tissue and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to gain insight into how the balance between mutant and WT protein expression affects cardiomyocyte function. METHODS: Force measurements were performed in cardiomyocytes isolated from a HCM patient carrying a homozygous troponin T mutation (cTnT-K280N) and healthy donors. To discriminate between mutation-mediated and phosphorylation-related effects on Ca(2+)-sensitivity, cardiomyocytes were treated with alkaline phosphatase (AP) or protein kinase A (PKA). Troponin exchange experiments characterized the relation between mutant levels and myofilament function. To define mutation-mediated effects on Ca(2+)-dynamics we used CRISPR/Cas9 to generate hiPSC-CMs harbouring heterozygous and homozygous TnT-K280N mutations. Ca(2+)-transient and cell shortening experiments compared these lines against isogenic controls. RESULTS: Myofilament Ca(2+)-sensitivity was higher in homozygous cTnT-K280N cardiomyocytes and was not corrected by AP- and PKA-treatment. In cTnT-K280N cells exchanged with cTnT-WT, a low level (14%) of cTnT-K280N mutation elevated Ca(2+)-sensitivity. Similarly, exchange of donor cells with 45 ± 2% cTnT-K280N increased Ca(2+)-sensitivity and was not corrected by PKA. cTnT-K280N hiPSC-CMs show elevated diastolic Ca(2+) and increases in cell shortening. Impaired cardiomyocyte relaxation was only evident in homozygous cTnT-K280N hiPSC-CMs. CONCLUSIONS: The cTnT-K280N mutation increases myofilament Ca(2+)-sensitivity, elevates diastolic Ca(2+), enhances contractility and impairs cellular relaxation. A low level (14%) of the cTnT-K280N sensitizes myofilaments to Ca(2+), a universal finding of human HCM. Elsevier, Inc 2022-09 /pmc/articles/PMC10160007/ /pubmed/37159677 http://dx.doi.org/10.1016/j.jmccpl.2022.100007 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Sequeira, Vasco Wang, Lili Wijnker, Paul J.M. Kim, Kyungsoo Pinto, Jose R. dos Remedios, Cris Redwood, Charles Knollmann, Bjorn C. van der Velden, Jolanda Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy |
title | Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy |
title_full | Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy |
title_fullStr | Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy |
title_full_unstemmed | Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy |
title_short | Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy |
title_sort | low expression of the k280n tnnt2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160007/ https://www.ncbi.nlm.nih.gov/pubmed/37159677 http://dx.doi.org/10.1016/j.jmccpl.2022.100007 |
work_keys_str_mv | AT sequeiravasco lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy AT wanglili lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy AT wijnkerpauljm lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy AT kimkyungsoo lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy AT pintojoser lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy AT dosremedioscris lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy AT redwoodcharles lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy AT knollmannbjornc lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy AT vanderveldenjolanda lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy |